Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | PHGDH | O43175 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3258672 | 0.86 | — | — | |
| SCHEMBL10748084 | 0.85 | KDM4E (0.44) | USP2KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL10748936 | 0.85 | KDM4E (0.44) | USP2KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL7680464 | 0.82 | — | — | |
| SCHEMBL1072392 | 0.82 | MEN1 (0.30) | USP2 | |
| SCHEMBL5772531 | 0.80 | — | — | |
| SCHEMBL1467290 | 0.79 | KDM4E (0.45) | USP2KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL3532703 | 0.79 | KDM4E (0.45) | USP2KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL1467291 | 0.79 | KDM4E (0.45) | USP2KDM4EALDH1A1HSD17B10TSHR | |
| SCHEMBL21872268 | 0.78 | KDM4E (0.41) | USP2KDM4EALDH1A1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2024-03-07 | — | — | US | claimed |
| EP-4258879-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2023-10-18 | — | — | EP | claimed |
| CN-116583569-A | Surface antimicrobial treatment | 克罗星有限公司 | 2023-08-11 | — | — | CN | claimed |
| WO-2022123441-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2022-06-16 | — | — | WO | claimed |
| EP-2179001-A1 | A LIQUID COMPOSITION SUITABLE FOR USE AS A CORROSION INHIBITOR AND METHOD FOR ITS PREPARATION | Bromine Compounds Ltd. (IL) | 2010-04-28 | — | — | EP | claimed |
| US-20090050853-A1 | Liquid composition suitable for use as a corrosion inhibitor and a method for its preparation | BROMINE COMPOUNDS LTD. (IL) | 2009-02-26 | — | — | US | claimed |
| WO-2009022332-A1 | A LIQUID COMPOSITION SUITABLE FOR USE AS A CORROSION INHIBITOR AND METHOD FOR ITS PREPARATION | BROMINE COMPOUNDS LTD. (IL) | 2009-02-19 | — | — | WO | claimed |
| CN-1252112-C | Method for preparing perfomed polymer for monocomponent polyurethane foam gule | SHANGHAI CITY SYNTHETIC RESIN (CN) | 2006-04-19 | — | — | CN | claimed |
| CN-1528801-A | Method for preparing perfomed polymer for monocomponent polyurethane foam gule | 上海市合成树脂研究所 | 2004-09-15 | — | — | CN | claimed |
| CN-1120192-C | Active methano-compound containing tertiary amine for improving stability of size of polyurethane | AIR PROD & CHEM (US) | 2003-09-03 | — | — | CN | claimed |
| CN-1300792-A | Active methano-compound containing tertiary amine for improving stability of size of polyurethane | AIR PROD & CHEM (US) | 2001-06-27 | — | — | CN | claimed |
| US-4391721-A | Dispersant viscosity index improver comprising reaction product of a styrene-maleic anhydride copolymer, an aliphatic alcohol and a tertiary amino alcohol | STANDARD OIL COMPANY (INDIANA) (US) | 1983-07-05 | — | — | US | claimed |
| US-4103087-A | REACTING TERTIARY AMINOALKANOL WITH A SECONDARY AMINE IN PRESENCE OF AN ALUMINUM PHOSPHATE CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-07-25 | — | — | US | claimed |
| US-4095022-A | PHOSPHORUS COMPOUNDS, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-06-13 | — | — | US | claimed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | claimed |
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2024-03-07 | — | — | US | disclosed |
| EP-4258879-A1 | SURFACE ANTIMICROBIAL TREATMENTS | Crossing S.r.l. (IT) | 2023-10-18 | — | — | EP | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4018723-A | Morpholino-modified polysiloxane-polyoxyalkylene copolymers and their use as foam stabilizers in polyurethanes | UNION CARBIDE CORPORATION (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074437-A1 | SURFACE ANTIMICROBIAL TREATMENTS | CUTA, ETF1, SFN | USP2 819/4885KDM4E 3012/4885ALDH1A1 3255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.